Propofol Injection, Emulsion
Product Images NDC 0069-0209

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 0069-0209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Propofol 01)

FDA Label Image

Figure (Propofol 02)

FDA Label Image

Logo (Propofol 03)

Logo (Propofol 03)
The text above provides information about a product called "Injectables" that is distributed by Plizer Labs, which is a division of Pfizer Inc. The product seems to be related to medical treatments and may be administered through injections.*
FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
This is a description of a Sterile Nonpyrogenic Propofol Injectable Emulsion used for intravenous administration. The dosage information is present in the package insert. It should be used with aseptic technique and the ingredients cannot be frozen. Rest of the text contains manufacturing information and lot number.*
FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Principal Display Panel (20 mL Vial Carton)
Propofol Injectable Emulsion USP is a sterile and nonpyrogenic solution that should be stored between 4 to 25°C (40 to 77°F) and not frozen. It should be administered only by persons trained in administering general anesthesia and with facilities for maintaining airway patency, artificial ventilation, and oxygen enrichment and circulatory resuscitation. Each mL of the solution contains Propofol, soybean oil, lycerin, egg lecithin, and edetate disodium; with sodium hydroide to adjust pH. The solution requires strict aseptic technique while handling and contains EDTA, which inhibits microbial growth up to 12 hours. The solution must be discarded within 12 hours of opening. The package insert contains dosage information.*
FDA Label Image

Principal Display Panel (50 mL Vial Label)

Principal Display Panel (50 mL Vial Label)
This text appears to be a product label for an injectable medication called Propofol. It includes details such as the strength of the medication (500mg/50mL), instructions for use (intravenous administration), and a caution to shake well before use. The label also includes information such as a National Drug Code (NDC) number and some dosage information.*
FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Principal Display Panel (50 mL Vial Carton)
This text contains information regarding the use and administration of Propofol Injectable Emulsion, USP, which comes in twenty 50mL vials for single-patient use. It is recommended to shake the vial well before using it. The text provides a dosage of 500mg/50mL for intravenous administration.*
FDA Label Image

Principal Display Panel (100 mL Vial Label)

Principal Display Panel (100 mL Vial Label)
This is a description of a medication called Propofol Injectable for intravenous administration. It is available in a single sterile 100mL vial, with each mL containing 10mg of Propofol. The medication should be used with strict aseptic technique and shaken before use. The vial contains soybean oil, glycerin, egg lecithin, and sodium hydroxide, as well as EDTA to inhibit microbial growth for up to 12 hours. The medication should be discarded after 12 hours. The manufacturer is Pfizer, and the product is made in Switzerland.*
FDA Label Image

Principal Display Panel (100 mL Vial Carton)

Principal Display Panel (100 mL Vial Carton)
This is a description of Propofol Injectable Emulsion USP. It is a sterile and non-pyrogenic medication that should be stored within a temperature range of 4 to 25°C and cannot be frozen. It is meant for intravenous administration during surgery by trained medical personnel who have access to the equipment needed for maintaining the patient's airway and oxygen levels, and the ability to resuscitate in emergency situations. The medication contains EDTA, which helps in inhibiting microbial growth for up to 12 hours and must be discarded within 12 hours of opening. Each vial of Propofol Injectable Emulsion USP contains 100 mg/mL of propofol, edetate disodium (0.006%), and sodium hydroxide to adjust pH. It should be used with strict aseptic technique. This medication is manufactured by Dipsan Pharmaceuticals and distributed by Piramal.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.